Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Future of Scar Treatment: Early Intervention, New Technologies, and Personalized Therapies
Description
Dr. Jill Weibel discussed the future of scar treatment as moving beyond treating mature scars toward early intervention, scar prevention, and personalized care. She emphasized that scars are dynamic and depend on timing, inflammation, angiogenesis, collagen remodeling, tension, genetics, and patient-specific factors. The talk highlighted a shift from one-off treatments to phase-aligned combination therapy targeting inflammation, abnormal blood vessels, extracellular matrix deposition, and symptoms like pain and itching. She reviewed current and emerging technologies, including fractional lasers, pulse dye lasers, photobiomodulation, red light therapy, robotics, AI-guided imaging and dosing, OCT and other imaging tools, micro-coring, femtosecond lasers, wearable scar monitors, predictive modeling, and smart drug-delivery or microneedling patches. A major theme was that early treatment after injury or suture removal can improve outcomes and sometimes prevent scars entirely, especially in surgical, burn, and acne scars. She also noted that keloids may represent a distinct disease process with genetic and vascular components, suggesting future roles for systemic, gene-based, and precision therapies. Overall, she concluded that the future of scar management is bright, centered on prevention, personalization, and smarter multimodal treatment.
View moreConclusions
- The presentation concludes that the best scar outcome is no visible scar, which requires early intervention rather than waiting to treat mature scars.
- Scar formation is driven by a time-dependent interplay of inflammation, dysfunctional angiogenesis, fibrosis, collagen cross-linking, and mechanical tension, so treatment must be matched to the wound-healing phase.
- Early vascular control, especially with pulsed dye laser, appears to improve perfusion, reduce erythema, limit thickness, and promote maturation of hypertrophic scars.
- Ablative fractional lasers can normalize scar architecture and vascularity while remodeling collagen, supporting their role as a core scar-treatment technology.
- Combination therapy is likely more effective than any single modality because scars are biologically complex and multi-factorial.
- Photobiomodulation and red-light therapy may help wound healing and scar control by improving cellular energy, oxygenation, and inflammation, but they are best viewed as adjunctive tools.
- Future scar care will likely become more personalized through AI-guided lasers, advanced imaging such as OCT and RCM, and real-time adjustment of treatment parameters.
- Wearable monitoring and drug-delivery systems may enable earlier detection and more continuous, targeted scar prevention.
- Acne scars are framed as largely inflammation-driven, suggesting that controlling active acne and post-inflammatory change early could prevent many scars.
- Keloids are portrayed as a genetically influenced disease process rather than a simple scar, implying that systemic or gene-based therapies may eventually be needed.
- Mechanical offloading and reduction of tension are important because mechanotransduction contributes to fibrosis and scar persistence.
- The overall direction of the field is shifting from scar revision toward proactive prevention, regenerative healing, and personalized, phase-specific intervention.
- Huhtala et al.; Micromachines (2022).
- The surprising science behind red-light therapy – and how it really works. Nature.com. DAVID OZOG.#10.1038/d41586-026-00878-1
- Photobiomodulation improves stroke (in rodents). AHA Journals; pubmed.ncbi.nlm.nih.gov.
- Vascularity and thickness changes in immature hypertrophic scars treated with a pulsed dye laser. Deng et al. 2020, Lasers Surg. & Med.#10.1002/lsm.23366
- Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Kischer et al. Hum Path. 1982;13:819-24.#10.1016/s0046-8177(82)80078-6
- J Clin Aesthet Dermatol. 2022 Sep;15(9):30-39. PMID: 36213601. An Atlas of Optical Coherence Tomography: Elucidating In Vivo Differences of Scar Types Using OCT In Order to Guide Laser Treatment Parameters.
- Wearable Technology for Chronic Wound Monitoring. Frontiers in Bioengineering and Biotechnology (2018).
- Wearable patches for transdermal drug delivery. Acta Pharm Sin B. 2023 May 15;13(6):2298–2309.#10.1016/j.apsb.2023.05.009
- Small interfering RNA microneedle patches versus silicone sheets in reducing postoperative scars: a randomized single-blinded intraindividually controlled clinical trial. Lim et al, British Journal of Dermatology, Volume 192, Issue 1, January 2025, Pages 19–26.#10.1093/bjd/ljae347
- Jaspers et al., Burns 2017, 43:1044–50.
- Ozog, David M.; Moy, Ronald L., et al. JAMA Dermatology, 2013.
- Vogel et al., Exp Eye Res; SciDirect Review (2025–2026).
- Amadeu et al.
- Fullerton et al.